These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 8186277)

  • 1. Out-patient medical care in Edinburgh for IDU-related HIV.
    Brettle RP; Willocks L; Hamilton BA; Shaw L; Leen CL; Richardson A; Gore SM
    AIDS Care; 1994; 6(1):49-58. PubMed ID: 8186277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychoeducational group approach: HIV risk reduction in drug users.
    Sorensen JL; London J; Heitzmann C; Gibson DR; Morales ES; Dumontet R; Acree M
    AIDS Educ Prev; 1994 Apr; 6(2):95-112. PubMed ID: 8018443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of antiretroviral therapies by HIV-infected persons receiving methadone maintenance.
    Stein MD; Urdaneta ME; Clarke J; Maksad J; Sobota M; Hanna L; Markson LE
    J Addict Dis; 2000; 19(1):85-94. PubMed ID: 10772605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methadone treatment as a determinant of HIV risk reduction among injecting drug users: a nested case-control study.
    Serpelloni G; Carrieri MP; Rezza G; Morganti S; Gomma M; Binkin N
    AIDS Care; 1994; 6(2):215-20. PubMed ID: 8061081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On-site medical care in methadone maintenance: associations with health care use and expenditures.
    Gourevitch MN; Chatterji P; Deb N; Schoenbaum EE; Turner BJ
    J Subst Abuse Treat; 2007 Mar; 32(2):143-51. PubMed ID: 17306723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outpatient medical care of injection drug use related HIV.
    Brettle RP; Gore SM; McNeil A
    Int J STD AIDS; 1992; 3(2):96-100. PubMed ID: 1315159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-reported reasons among HIV-infected patients for missing clinic appointments.
    Park WB; Kim JY; Kim SH; Kim HB; Kim NJ; Oh MD; Choe KW
    Int J STD AIDS; 2008 Feb; 19(2):125-6. PubMed ID: 18334069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Risk reduction and intravenous drug use abstinence in patients with HIV infection. The SEROCO group].
    Meyer L; Wade A; Persoz A; Boué F; Dellamonica P; Caroli-Bosc C; Carré N
    Rev Epidemiol Sante Publique; 1998 Feb; 46(1):34-9. PubMed ID: 9533232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safe sex? Misconceptions, gender differences and barriers among injection drug users: a focus group approach.
    Weiss SH; Weston CB; Quirinale J
    AIDS Educ Prev; 1993; 5(4):279-93. PubMed ID: 8297708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Substitution as a possibility for the treatment of opiate dependent patients].
    von Bardeleben U; Petitjean S; Stohler R; Natsch C; Ladewig D
    Psychiatr Prax; 1994 Jan; 21(1):7-9. PubMed ID: 8146246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study.
    Roux P; Carrieri MP; Villes V; Dellamonica P; Poizot-Martin I; Ravaux I; Spire B;
    Addiction; 2008 Nov; 103(11):1828-36. PubMed ID: 18778390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug use among the urban poor in Kolkata: behaviour and environment correlates of low HIV infection.
    Panda S; Saha U; Pahari S; Nathan M; Poddar S; Neogi D; Sarkar M; Pal NK; Mahalanabis D
    Natl Med J India; 2002; 15(3):128-34. PubMed ID: 12186324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Missed appointments in an outpatient clinic for adolescents, an approach to predict the risk of missing.
    Chariatte V; Berchtold A; Akré C; Michaud PA; Suris JC
    J Adolesc Health; 2008 Jul; 43(1):38-45. PubMed ID: 18565436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compliance with return appointments for reproductive health care among adolescent Norplant users.
    Rainey DY; Parsons LH; Kenney PG; Krowchuk DP
    J Adolesc Health; 1995 May; 16(5):385-8. PubMed ID: 7662689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Two-year follow-up of an opioid-user cohort treated with high-dose buprenorphine (Subutex)].
    Fhima A; Henrion R; Lowenstein W; Charpak Y
    Ann Med Interne (Paris); 2001 Apr; 152 Suppl 3():IS26-36. PubMed ID: 11435992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cross-sectional study on factors including HIV testing and counselling determining unsafe injecting practices among injecting drug users of Manipur.
    Sarkar S; Panda S; Sarkar K; Hangzo CZ; Bijaya L; Singh NY; Das N; Agarwal A; Chatterjee A; Deb BC
    Indian J Public Health; 1995; 39(3):86-92. PubMed ID: 8690497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [HIV prevention in HIV-positive drug addicts. A methadone-supported model].
    Oertle D; Edelmann R; Ostewalder J; Vernazza PL; Galeazzi RL
    Schweiz Med Wochenschr; 1993 Dec; 123(48):2284-92. PubMed ID: 8272803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of outcome in methadone programs: effect of HIV counseling and testing.
    Farley TA; Cartter ML; Wassell JT; Hadler JL
    Conn Med; 1994 Mar; 58(3):165-71. PubMed ID: 8039381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST).
    Spire B; Lucas GM; Carrieri MP
    Int J Drug Policy; 2007 Aug; 18(4):262-70. PubMed ID: 17689374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Observational analysis of German injecting drug users (IDU): survival with and without methadone maintenance treatment. German AIDS Study Group GASG/IdkF.
    Eur J Med Res; 1996 Jan; 1(4):209-14. PubMed ID: 9445761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.